Search Results - elisabeth+heath




2 Results Sort By:
Identification of Galeterone's mechanism of action leading to novel treatment therapies for castrate resistant prostate cancer (CRPC)
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (HRPC), is a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT). The need for effective therapies for these difficult to treat cancers is gaining prominence in the prostate cancer market. The global CRPC market is poised...
Published: 11/19/2020   |   Inventor(s): Qingping Dou, Huanjie Yang, Elisabeth Heath
Keywords(s):  
Category(s): Life Science, Oncology, Pharmaceuticals, Receptors/targets, Process/Procedure, Small molecule, Therapeutics
Level of Galectin-3 protein in human blood improves PSA test results
Level of Galectin-3 Protein in Human Blood Improves PSA Test Results WSU Tech#: 13-1133 Technology Summary: For determining prostate cancer aggressiveness, PSA alone is not reliable, as it gives a high number of false positive and false negative results. There are about 25,000 publications on other markers in addition to PSA and as of yet, none...
Published: 5/19/2017   |   Inventor(s): Avraham Raz, Vitaly Balan, Elisabeth Heath, Lance Heilbrun
Keywords(s):  
Category(s): Medical, Biomedical, Diagnostics, Oncology